Your Success, Our Priority
Tailored For Your Success
Conducting pre-clinical and clinical trials to test new drugs, therapies, or medical devices. This includes activities like patient recruitment, testing, and data analysis.
Researching and developing new pharmaceutical compounds, including screening potential drug candidates, synthesizing and testing new molecules, and optimizing their effectiveness and safety.
Designing and prototyping new medical devices or improving existing ones. This includes activities such as developing new technology, testing device functionality, and conducting usability studies.
Investigating genetic and protein-based mechanisms to understand diseases better and develop targeted treatments. This includes sequencing genomes, analyzing gene expression, and studying protein interactions.
Using computational tools and algorithms to analyze large datasets from experiments or clinical studies. This includes developing software, creating models, and interpreting complex biological data.
Life science companies, from pharmaceutical and biotech firms to medical device manufacturers, often invest heavily in research and development. By securing an R&D tax credit loan from Buzz Capital, these companies can accelerate their growth and innovation. We offer rapid access to funds, often within days, allowing life science firms to quickly reinvest in promising projects.
Our loans also help mitigate financial risk by providing flexible repayment terms and the option to use future R&D tax credit payments as security or collateral. With up to 80% of the value of your R&D tax credits available as a cash payment, Buzz Capital can offer a significant financial boost to life science companies of all sizes. Whether you’re developing new pharmaceuticals, medical devices, or biotech solutions, our R&D tax credit loans can provide the capital you need to drive your business forward.